Day: October 14, 2021

BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that it has submitted its Type II variation application to the European Medicines Agency (EMA) for IMCIVREE® (setmelanotide) for the treatment of obesity and control of hunger in adult and pediatric patients six years of age and older with Bardet-Biedl syndrome (BBS) or Alström syndrome. “This marks an important milestone toward our goal of delivering IMCIVREE globally to patients with BBS and, ultimately, many other rare genetic diseases of obesity,” said David Meeker, M.D., Chairman, President and Chief Executive Officer of Rhythm. “IMCIVREE achieved clinically meaningful and statistically significant...

BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that it has submitted its Type II variation application to the European Medicines Agency (EMA) for IMCIVREE® (setmelanotide) for the treatment of obesity and control of hunger in adult and pediatric patients six years of age and older with Bardet-Biedl syndrome (BBS) or Alström syndrome. “This marks an important milestone toward our goal of delivering IMCIVREE globally to patients with BBS and, ultimately, many other rare genetic diseases of obesity,” said David Meeker, M.D., Chairman, President and Chief Executive Officer of Rhythm. “IMCIVREE achieved clinically meaningful and statistically significant...

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it will report financial results for the third quarter 2021 after market close on Thursday, October 28, 2021. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Individuals interested in listening to the conference call may do so by dialing 877-705-6003 for domestic callers or 201-493-6725 for international callers. Please reference Conference ID: 13724010. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com. About...

NEW YORK, Oct. 14, 2021 (GLOBE NEWSWIRE) — Anghami Inc. (“Anghami” or the “Company”), the leading music streaming platform and service in the Middle East and North Africa, and Vistas Media Acquisition Company Inc. (NASDAQ: VMAC), a publicly traded special purpose acquisition company led by CEO F. Jacob Cherian and co-founders Saurabh Gupta and Abhayanand Singh, announced today they have filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form F-4 with respect to their proposed business combination (the “Business Combination”). The Form F-4 filing can be found here. The registration statement was previously submitted confidentially to the SEC on August 2, 2021 and amended on September 21, 2021. The registration statement has been filed with the SEC but has not yet become effective. The securities...

Medical Grand Opening this Saturday and Sunday, October 16-17, 2021 PHOENIX, Oct. 14, 2021 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQX: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced that the Grand Opening of its Commonwealth Alternative Care (“CAC”) Brockton, Massachusetts location will take place this Saturday and Sunday, Oct. 16-17. Additionally, the Massachusetts Cannabis Control Commission (“CCC” or the “Commission”) has awarded the CAC Brockton location a final adult-use retail establishment license, with sales to commence pending final inspection by the CCC. The Grand Opening celebration will kick-off on Saturday at 9:30 a.m. with a ribbon-cutting ceremony...

MANCHESTER, N.H., Oct. 14, 2021 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it will release financial results for the second quarter fiscal year 2022 prior to the market opening on Thursday, October 28, 2021. Following the press release, the Company will host a conference call at 8:30AM Eastern time the same day. Ravi Vig, President and Chief Executive Officer, and Paul Walsh, Senior Vice President, Finance & Administration and Chief Financial Officer, will discuss the Company’s results and business outlook. Analysts and investors are invited to join the conference call using the following information: What: Allegro MicroSystems’ Q2 Fiscal 2022 Earnings Conference CallWhen: Thursday, October 28, 2021Time: 8:30 a.m. EDT Conference Dial-in: 1-833-665-0677 International Dial-in: 1-929-517-0172Conference...

PARIS, FRANCE, October 14th, 2021 – Financial Report for First half Fiscal 2021 available The Financial report for the First half Fiscal 2021 is available online and filed with the Autorité des marchés financiers (AMF). This document is available on Tarkett’s website, www.tarkett.com, under section “Investors/ Corporate documents”. It includes the condensed consolidated financial statements for the first half of Fiscal 2021, the First half activity report, the statement of responsibility for the First half financial report as well as the auditors’ report on the limited review of the above-mentioned financial statements. *** Group Financial Officer Tarkett – Raphaël Bauer – investors@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES WINNIPEG, Manitoba, Oct. 14, 2021 (GLOBE NEWSWIRE) — Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) announced today an operational and financing update. AGI Reaffirms 2021 OutlookAGI reaffirms its previously disclosed outlook for near-term financial results, which includes expectations for:Q3 2021 sales to increase relative to Q3 2020 but, as expected, higher steel prices and supply chain challenges are anticipated to result in lower adjusted EBITDA1 on a year-over-year basis Strong sales as well as adjusted EBITDA growth in Q4 2021 Very robust backlogs across AGI which were up 99% year-over-year as of September 30, 2021 Despite the anticipated steel impact in Q3 2021, full year 2021 adjusted EBITDA...